Cargando…

Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment

CD90 (Thy-1) plays important roles in oncogenesis and shows potential as a candidate marker for cancer stem cells (CSCs) in various malignancies. Herein, we investigated the expression of CD90 in pancreatic adenocarcinoma (PDAC), with a comparison to normal pancreas and non-malignant pancreatic dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jianhui, Thakolwiboon, Smathorn, Liu, Xinhua, Zhang, Min, Lubman, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275230/ https://www.ncbi.nlm.nih.gov/pubmed/25536077 http://dx.doi.org/10.1371/journal.pone.0115507

Ejemplares similares

Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer
por: Yang, Rui, et al.
Publicado: (2016)

Editorial: Thy1/CD90 Surface Glycoprotein: Sensor of Microenvironment?
por: Felley-Bosco, Emanuela, et al.
Publicado: (2019)

Clinical presentations and treatment outcomes of Hashimoto encephalopathy at Siriraj Hospital – Thailand’s largest national tertiary referral center
por: Dumrikarnlert, Chaisak, et al.
Publicado: (2023)

Tenascin-C: A Novel Candidate Marker for Cancer Stem Cells in Glioblastoma Identified by Tissue Microarrays
por: Nie, Song, et al.
Publicado: (2014)

CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias
por: Pei, Xiucong, et al.
Publicado: (2016)

De Novo Myasthenia Gravis Induced by Atezolizumab in a Patient with Urothelial Carcinoma
por: Thakolwiboon, Smathorn, et al.
Publicado: (2019)

Thy-1/CD90 a Bidirectional and Lateral Signaling Scaffold
por: Leyton, Lisette, et al.
Publicado: (2019)

The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2013)

CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
por: Sauzay, Chloé, et al.
Publicado: (2019)

Thy-1 (CD90), Integrins and Syndecan 4 are Key Regulators of Skin Wound Healing
por: Pérez, Leonardo A., et al.
Publicado: (2022)

Marginal Zone B Cells in Neonatal Rats Express Intermediate Levels of CD90 (Thy-1)
por: Dammers, Peter M., et al.
Publicado: (2002)

A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells
por: Moraes, Daniela A., et al.
Publicado: (2016)

THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC Activation
por: Chen, Luo, et al.
Publicado: (2023)

High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors
por: Lobba, Aline Ramos Maia, et al.
Publicado: (2018)

Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response
por: Furlong, Suzanne, et al.
Publicado: (2018)

Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma
por: Zhu, Jianhui, et al.
Publicado: (2017)

CD90/THY1 is over-expressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker
por: True, Lawrence D, et al.
Publicado: (2010)

Visualization of Intrapulmonary Lymph Vessels in Healthy and Inflamed Murine Lung Using CD90/Thy-1 as a Marker
por: Kretschmer, Sarah, et al.
Publicado: (2013)

CD90- (Thy-1-) High Selection Enhances Reprogramming Capacity of Murine Adipose-Derived Mesenchymal Stem Cells
por: Kawamoto, Koichi, et al.
Publicado: (2013)

THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus Infection
por: Li, Qingxue, et al.
Publicado: (2015)

The present and future of systemic and microenvironment-targeted therapy for pancreatic adenocarcinoma
por: Mehta, Arnav, et al.
Publicado: (2020)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
por: Zhang, Jingchang, et al.
Publicado: (2022)

Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
por: Smith, Caitlyn, et al.
Publicado: (2022)

Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
por: Gola, Michał, et al.
Publicado: (2022)

The GPI-Anchored Protein Thy-1/CD90 Promotes Wound Healing upon Injury to the Skin by Enhancing Skin Perfusion
por: Pérez, Leonardo A., et al.
Publicado: (2022)

The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations
por: Luong, An B., et al.
Publicado: (2020)

Phytate Intake, Health and Disease: “Let Thy Food Be Thy Medicine and Medicine Be Thy Food”
por: Pujol, Antelm, et al.
Publicado: (2023)

Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor Microenvironment and Barriers to Treatment
por: Kane, Sujata, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma
por: Lambin, Thomas, et al.
Publicado: (2022)

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Skorupan, Nebojsa, et al.
Publicado: (2022)

Translocation of Oral Microbiota into the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment
por: McKinley, Kelley N. L., et al.
Publicado: (2023)

Let food be thy medicine and medicine be thy food?
por: Stauss, Madelena, et al.
Publicado: (2018)

CD200 promotes immunosuppression in the pancreatic tumor microenvironment
por: Choueiry, Fouad, et al.
Publicado: (2020)

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
por: Nie, Yuan, et al.
Publicado: (2023)

Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration
por: Thakolwiboon, Smathorn, et al.
Publicado: (2023)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical Trials
por: Mejia, Isabel, et al.
Publicado: (2020)

The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
por: Herremans, Kelly M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djc0jeo3eqaqodfoc613eu0v9r